Boston Scientific EPS (Basic) decreased by 11.8% to $0.45 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.4%, from $0.38 to $0.45. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows an upward trend with a 29.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
is_eps_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.12 | $0.28 | $0.06 | $0.07 | $0.17 | $0.12 | $0.09 | $0.21 | $0.18 | $0.34 | $0.35 | $0.34 | $0.22 | $0.32 | $0.38 | $0.46 | $0.54 | $0.51 | $0.45 |
| QoQ Change | — | +133.3% | -78.6% | +16.7% | +142.9% | -29.4% | -25.0% | +133.3% | -14.3% | +88.9% | +2.9% | -2.9% | -35.3% | +45.5% | +18.7% | +21.1% | +17.4% | -5.6% | -11.8% |
| YoY Change | — | — | — | — | +41.7% | -57.1% | +50.0% | +200.0% | +5.9% | +183.3% | +288.9% | +61.9% | +22.2% | -5.9% | +8.6% | +35.3% | +145.5% | +59.4% | +18.4% |